ORPHAZYME TO PRESENT AT INVESTORDAGEN 2018

Copenhagen, September 18, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders Hinsby, Chief Executive Officer at Orphazyme, will be presenting at Dansk Aktionærforening’s InvestorDagen in Copenhagen, Denmark, today, September 18, 2018 at 10.20 AM CET.

 For free participation, please visit www.InvestorDagen.dk and use the code VIPOrphazyme2018.